Colorectal Gastric Articles & Analysis
2 articles found
CDH1 loss is particularly significant in epithelial cancers, such as breast, gastric, and colorectal cancers. In breast cancer, for example, the loss of CDH1 expression is associated with a more aggressive phenotype and poorer prognosis. ...
It is a transmembrane glycoprotein expressed in normal tissues and many epithelial tumors, including breast, cervical, colorectal, esophageal, gastric, and lung cancers. In NSCLC, high Trop-2 expression was observed in 64% of adenocarcinomas and 75% of squamous cell carcinomas (SqCCs). ...